MAPT and amyloidosis: Some studies support the evidence that markers of amyloidosis (Aβ42, A+) and tangles pathology (p-tau, T+), but not injury markers (t-tau, N+), are necessary for brain volume changes that are detectable in early phases [142,143,144].